On 20 May 2026, the Veterinary Medicines Directorate (VMD) launched a new digital service for reporting adverse events associated with Veterinary Medicinal Products (VMPs) at: Report a problem with an animal medicine or animal exposed to human medicine, making it easier for veterinary professionals and animal owners to submit reports directly to the regulator.
MAHs should now be prepared to receive adverse event reports from the VMD.
The VMD reminds MAHs that the guidance within Guideline III Adverse event reporting – GOV.UK should be followed and highlighted the following three points:
- Any VMD narratives or NCA comments included in the narrative should be retained within the case without being edited or replaced
- When the VMD is the originator of a case, the VMD’s version of the adverse event report must always reflect all products involved. Therefore, MAHs should refrain from sending follow-up reports which have been amended to suit their VMPs only.
- The VMD should only be contacted regarding suspected duplicates for which the VMD is the originator of one of the cases. For other suspected duplicates, the VMD recommends that the MAH contacts the originator MAH for the case in question
The VMD also indicates that, where a reporter requests confirmation from an MAH that an adverse event report has been submitted to the VMD, provision of the VMD’s local PV Case Reference number can be provided by the MAH to the reporter.
Keeping up with evolving regulatory requirements is essential for maintaining compliant pharmacovigilance processes. If you would like to discuss how these changes may affect your organization, we’d be happy to help.
Contact us: [email protected]
